Gene therapy at the Retina Foundation

Beacon Therapeutics Reports Encouraging Interim Results from Phase 2 Clinical Trial for XLRPПодробнее

VISIONS 2022 | Clinical & Research Updates: Retinitis Pigmentosa (RP)Подробнее

News | Vision Improvements Reported for RP Patients in Phase 2B Nanoscope Clinical TrialПодробнее

S1E4: The Retina Radar With Dr. Arshad Khanani: Gene Therapy With Dr. Dante PieramiciПодробнее

Emerging Therapies for Inherited Retinal DiseasesПодробнее

2022 GFPD Family & Scientific Conference: Retinal Gene Therapy SessionПодробнее

Genetics in Glaucoma Diagnosis and Treatment: Now and in the Future —Janey L. Wiggs, MD, PhDПодробнее

Eye on the Cure Podcast | Episode 24: Ash Jayagopal, PhDПодробнее

Eye on the Cure Podcast | Episode 53: David Birch, PhDПодробнее

Eyes on the Future: Glaucoma Research Update from the 2024 Glaucoma Patient SummitПодробнее

Role of gene therapy for Retinal Dystrophies and Retinitis Pigmentosa#genetherapy#blindness#researchПодробнее

Lecture: Gene Therapy and Delivery Strategies for AMD and Diabetic RetinopathyПодробнее

Neuroprotection: A New Path for Glaucoma Patients—Ahmara Gibbons Ross, MD, PhD - 2022 Weston LectureПодробнее

Pivotal Clinical Trials for Retinitis Pigmentosa and Usher Syndrome UnderwayПодробнее

Retina Foundation Eye on Innovation-Stem Cell Research in Age-Related Macular Degeneration-09/2022Подробнее

Retina Foundation Scientist Hour: A Conversation with Kaylie JonesПодробнее

The GFPD | World Orphan Drug Conference Presentation | July 2022Подробнее

CRB1-Associated Inherited Retinal Diseases Forum | 11.12.22Подробнее

VISIONS 2022 Science Preview with Claire Gelfman, PhDПодробнее